Glaukos is a medical devices business based in the US. Glaukos shares (GKOS.US) are listed on the NYSE and all prices are listed in US dollars. Its last market close was $105.01 ā a decrease of 1.41% over the previous day. Glaukos employs 907 staff and has a trailing 12-month revenue of around $326.4 million.
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, Glaukos's shares have ranged in value from as little as $54.3801 up to $108.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Glaukos's is 1.103. This would suggest that Glaukos's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Historical closes compared with the last close of $105.01
| 1 week (2024-04-30) | 6.17% |
|---|---|
| 1 month (2024-04-07) | 4.35% |
| 3 months (2024-02-07) | 9.40% |
| 6 months (2023-11-07) | 63.62% |
| 1 year (2023-05-07) | 79.01% |
| 2 years (2022-05-05) | 153.95% |
| 3 years (2021-05-06) | 26.46% |
| 5 years (2019-05-07) | 42.93% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Glaukos P/E ratio, PEG ratio and EBITDA
Glaukos's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth ā to give 1.64. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Glaukos's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
A deep dive into the highlights and limitations of Frec.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
Check out our picks of the best ETF brokers for beginners, options trading, micro-investing and more.
Access remote advice, planning and portfolio management from this established financial services company.
Get familiar with Canada’s largest stock exchange and find out how to buy TSX stocks.
M1 Finance strikes a balance between self-directed and automated investing. What you need to know before you sign up.
What you need to know about investing in the leading indicator for the overall US stock market.
Take advantage of $0 trades and no investment minimums with this well-known broker.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.